This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring a cyclopropyl group attached to a pyrrolidinone ring, makes it valuable in the development of compounds targeting neurological disorders, including epilepsy and depression. Additionally, it serves as a building block in the creation of novel therapeutic agents aimed at modulating specific biological pathways. Researchers also explore its potential in designing inhibitors for enzymes involved in disease progression, particularly in cancer treatment. Its versatility in organic synthesis further extends its use in developing agrochemicals and fine chemicals.